Logo | Name | Σ | Employees | ||
---|---|---|---|---|---|
Medica Media Medica Media provides print, web-based and mobile media solutions for medical professionals. Written by doctors for doctors. Makers of PocketDr. PocketDr is the must-have app for all junior doctors with on-call responsibilities. It is an aide-memoire for the things you know - but may not recall quickly in the dead of night with constant bleeps and distractions. Succinct. Pre-digested info. When you need it. Contents include: - Checklists for assessment of the deteriorating patient. Be prepared for any NEWS call: Hypoxia, Tachycardia, Hypotension, low GCS. - Checklists for management of 21 acute medical conditions including: ACS, AF, Asthma, Delerium, Hyperkalaemia, … Type: Startup Activities: healthtech it services Technologies: Synthetic Biology | 12 | 2 | 11 | 1 | |
Nascent Biotech, Inc. Nascent’s development approach utilizes the immune system’s innate capabilities and selectivity. Nascent Biotech, Inc. (OTCMKTS:NBIO) is a public company, formed in March 2014, to continue development of Pritumumab, a human monoclonal antibody created by a number of leading scientists who have developed various monoclonal antibodies and cytokine treatments for oncology indications. Pritumumab recognizes a unique and proprietary antigen expressed on the surface of cancer cells and is being developed to treat brain and pancreatic cancers, both unmet clinical needs. NBIO’s clinical premise is that the most effective way to treat disease is to modulate (boost or suppress) the human body’s … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 1 | |
NestEgg Labs Clever Automation Made Simple NestEgg Labs is a company providing innovative lab automation tools for cell culture applications. We are developing the Ovation hardware along with software to control it remotely and sterile disposable parts. Ovation, our flagship product, is a smart incubator that automates cell culture processes and cellular assays. The combination of powerful lens-free microscopy and fluid handling reduces experimental errors and time consuming activities. The system allows for a range of workflows to be reliably automated remotely using cloud-based software. Ovation is an affordable, flexible, and fully controllable laboratory automation system that ensures a smoother workflow in … Type: Startup Activities: biotech deeptech Technologies: 3D Printing Synthetic Biology | 3 | 1 | 3 | 5 | |
The Care Machine Ltd Helping you scale-up your ideas and create a resilient business with compelling products that will change people's lives Our mission is to produce bespoke solutions for you by combining our unique engineering and science expertise with our business knowledge, project management and media engagement know-how. From advice on funding streams, to design and manufacture processes, to full project management of your idea, we can help you realise your goals and get your product where it needs to be; with the patient. Unlike other B2B consultancies, The Care Machine works in partnership with our medtech clients. We have created an adaptive … Type: Startup Activities: healthtech deeptech govtech Technologies: Synthetic Biology | 5 | 0 | 2 | 1 | |
FIC | Food Industry Consulting Food Safety is a Global Effort. Let's Save Lives Together. Food Industry Consulting (FIC), founded in 2008 by Soheila (Sonia) Akbarzadeh is a consulting firm that provides expert guidance and training to food companies in food safety and product development. Our team of food safety and food technologist specialists are dedicated to helping our clients run superior food safety programs and develop innovative products. We deliver live-virtual and on-site training for standardized Food Safety Preventive Controls Alliance (FSPCA) courses recognized by the U.S Food and Drug Administration (FDA). These courses include Preventive Controls (PC) for Human and Animal food, Foreign … Type: Startup Activities: foodtech Technologies: Synthetic Biology | 32 | 10 | 22 | 44 | |
Scaled Biolabs Inc. Working at the frontier of microfluidics, automation and machine learning to accelerate cell-based medicines. Scaled Biolabs accelerates the discovery and development of complex cell-based medicines, such as stem cell therapies and cancer immunotherapies. Their full stack optimization engine reduces complexity and time to market, by leveraging high-throughput, micro-scale cell culture, automation, and deep data insight. It also powers internal, grant funded programs such as developing a new gold standard for manufacturing dopaminergic neurons to treat Parkinson’s disease. Microfluidics, Biomedical R&D, Bioreactor, Single-cell Biology, Bioengineering, Stem Cells, Tissue Engineering, Cell Culture, Cell-based Assays, machine learning, and computer vision Type: Startup Activities: biotech deeptech Technologies: A.I. - Image Processing A.I. - Machine Learning A.I. Synthetic Biology | 0 | 0 | 0 | 1 | |
IDEABATIC SMILE- Smart last-mile Cooling System Reach out to every one however difficult the journey is. IDEABATIC is an award-winning social enterprise solving critical last-mile cold chain issues globally. IDEABATIC has developed a last-mile cooling system called SMILE (SMart last-mILE cooling system) that eliminates error and reduces spoilage in temperature-sensitive substances such as vaccines and bio-products. SMILE is freeze-free and fail-safe. It keeps vaccines and bio-products at between 2 and 8 degrees for 3 to 6 days during use without electricity. SMILE has been iterated, tested and field-proven. With the situation of the current pandemic, the logistics for vaccine delivery and … Type: Startup Activities: transporttech Technologies: Synthetic Biology | 1 | 0 | 0 | 2 | |
CardioScale Ltd. CardioScale is an Israeli medical device start-up founded 2012, pursuing a novel patent applied diagnostic for early detection of cardiovascular deterioration in various patients of heart failure and shock. Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 1 | |
CEBIOTEX Providing solutions for patients with cancer by helping surgeons in their oncological interventions. CEBIOTEX leverages nanofiber engineering to create a new medical product which can be infused with multiple agents, with special usefulness for low water solubility drugs. Proprietary technology allows to produce biocompatible-biodegradable membranes (protected by several patents in EU, USA and China), and without chemical interaction between the nanofiber polymer and the agent applied. First medical need targeted is in the field of Oncology: to reduce local recurrence and spreading of tumour cells, by improving local control of cancer after surgery. First product, CEB-01, is composed by our … Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 2 | 2 | 1 | 9 | |
MOWOOT Novel non-invasive, non-drug solution to chronic constipation MOWOOT is a growth stage medical device company targeting INTESTINAL TRANSIT DISORDERS with a novel, purely physical, NON-DRUG & NON-INVASVIVE SOLUTION. MOWOOT (legal name USMIMA SL) emerged out of the prestigious, Stanford Biodesign inspired ,program dHEALTH BCN and was founded in 2014. The Intermittent Colonic Exoperistalsis (ICE) treatment and the MOWOOT device have been developed in collaboration with one of Europes leading neuro-rehabilitation hospitals, Institut Guttmann (Barcelona), is IP protected and clinically proven. The medical device MOWOOT is a novel, purely physical, non-drug and non-invasive solution to treat intestinal transit disorders such as: … Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 7 | 2 | 4 | 7 | |
Aether Biomedical Making bionics accessible Aether Biomedical was founded on the premise of creating healthcare technology and robotics based on human-centered design. A culture focused on building the next generation of bionic devices, utilizing cutting-edge biosignal processing and software integration. After an expansion in Europe and Asia, we are now launching Zeus to the U.S market, with our U.S. headquarters in Chicago, IL. We have developed the Zeus hand, which is the strongest multi-articulating myoelectric hand in the world, providing 30-40% more grip force (152 Newtons) than existing market options! Apart from being the strongest hand, Zeus is highly robust as well. … Type: Startup Activities: deeptech healthtech Technologies: A.I. Robotics Synthetic Biology | 2 | 0 | 1 | 55 | |
MycoWorks We’re on a journey to Grow the Future of Materials. We’re on a journey to Grow the Future of Materials. How? By unlocking the unique properties of mycelium, the root structure of mushrooms. Our patented technology, Fine MyceliumTM, unleashes a new class of materials crafted from nature, engineered for performance, and built for a resilient future. Our impact on future generations steers our innovations today. From our expertise in mycology and materials science to our manufacturing innovations, we’re creating new possibilities for industry. We’re an outstanding team of scientists, engineers, product experts, artists, leaders—and you. Biomaterials, Biotechnology, Design, Composites, Sustainability, … Type: Startup Activities: biotech fashtech Technologies: New Materials Synthetic Biology | 8 | 1 | 1 | 223 | |
SmartBridge Health cancer care as it should be Problem Statistically speaking, one in three people will have cancer in his or her lifetime. Moreover, according to the Journal of Clinical Oncology, up to 44% of cancer diagnoses and treatment plans are incorrect. If there’s any moment in your life when you want to be absolutely certain, it is when you are diagnosed with cancer. It can take weeks or months to reach an oncologist. Imagine the stress, worry and fear of trying to find the right information and the right oncologists when cancer cells are growing exponentially in your body. We have … Type: Startup Activities: healthtech Technologies: Synthetic Biology | 1 | 1 | 0 | 1 | |
Tebubio Facilitators of Life Sciences Research We facilitate Life Sciences Research every day, contributing to advance Science for a brighter future. Through our local offices located across Europe, we support Life Sciences and Biotechnology Researchers with a unique, holistic range of solutions to advance their projects faster: - We enable researchers to be at the forefront in their Research with access to cutting-edge biological solutions sourced from reputed global Life Sciences suppliers, carefully selected by our Scientific Team for their relevance and evaluated for their ethical and legal compliance. - We accelerate their Research thanks to our Contract Research Services’ … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 15 | 2 | 13 | 81 | |
CeleScreen CeleScreen develops an innovative technology for the rapid screening of xenobiotics toxicity by means of Caenorhabditis elegans, a <1mm nematode, long-known model for human metabolism. It is a unique solution for systemic toxicity, reprotoxicity, teratogenicity, while avoiding vertebrate testing. Primary targets are in the cosmetics industry to face REACH demands. Celescreen has recently launched collaborative projects incorporating C. elegans and in silico approaches for drug development in human health. Incorporated in 2015, based at Hôpital Lariboisière in Paris, CeleScreen is a licensee of Assistance Publique - Hôpitaux de Paris (AP-HP), a major player in human health with >20,000 medical doctors. … Type: SMB Activities: cosmetics biotech deeptech healthtech Technologies: Synthetic Biology | 12 | 5 | 7 | 2 | |
PROMETHEE - Hépatites [Automatic translation follows] Hepatitis in the Alpine Arc (38,73,74) Prevention and screening of viral hepatitis and liver diseases. PROMETHEE Hepatitis in the Alpine Arc (Isère, Savoie, Haute Savoie) Health association created in 1999, part of the MRSI. Service for the prevention, awareness, screening of viral hepatitis and any other liver disease. Free awareness-raising for at-risk or specific audiences, the general public and professionals. Prevention and screening permanences with a diagnostic orientation (via TROD and FIBROSCAN®) with partners for their audiences. Organization of the Hepatitis Day in the Alpine Arc (information actions, screening in collaboration with the analysis laboratories and the … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 2 | 0 | 0 | 4 | |
Chiesi France [Automatic translation follows] Taking care of patients and the planet today for tomorrow! CHIESI is an Italian family biopharmaceutical group offering innovative therapeutic solutions to patients in 3 therapeutic areas: AIR (products and solutions for respiratory diseases from newborns to adults), RARE (treatments for rare and ultra-rare diseases), CARE (products and services in kidney and liver transplantation and prevention, in micronutrition) With nearly 6,500 employees worldwide, CHIESI is present in France across the entire value-added chain - R&D, production, distribution and provision to healthcare professionals and patients - with a turnover reaching nearly €175 million in 2022. Certified B-Corp, CHIESI … Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology | 8 | 3 | 5 | 341 | |
Airnov Healthcare Packaging Protecting Today, Preserving Tomorrow Protecting Today, Preserving Tomorrow. Type: SMB Activities: deeptech manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 126 | |
Cardax, Inc. Cardax is developing orally bioavailable anti-inflammatory compounds with robust safety for major unmet medical needs. Cardax (OTCQB: CDXI) is developing proprietary astaxanthin therapies for large unmet medical needs where oxidative stress and inflammation play important causative roles. Introduction Cardax is a development stage life sciences company that devotes substantially all of its efforts to developing nutraceutical and pharmaceutical products that provide the anti-inflammatory benefits of steroids or NSAIDS, but with exceptional safety profiles, as conferred by U.S. Food and Drug Administration (“FDA”) Generally Recognized as Safe (“GRAS”) designation at certain doses. Cardax is preparing proprietary nature-identical products and related derivatives … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 17 | |
Arrowhead Pharmaceuticals At Arrowhead Pharmaceuticals we are breaking the mold of medicine. We are pushing the boundaries of therapeutic development and revolutionizing how we care for hard-to-treat illnesses. As a company we harness collaboration and innovation to rapidly advance drugs from discovery to the clinic. All applicants: Please be aware of employment scams using Arrowhead’s name and the names of Arrowhead’s employees. All job related Arrowhead communication should come from the domain @arrowheadpharma.com. Biotech, Drug Development, Pharmaceuticals, and RNAi Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 3 | 1 | 1 | 556 | |
SCIEX The Power of Precision SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to find answers to the complex analytical challenges they face. The company's global leadership and world-class service and support in the capillary electrophoresis and liquid chromatography-mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery and development, food and environmental testing, forensics and clinical research. With over 50 years of proven innovation, SCIEX excels by listening to and understanding the ever-evolving needs of its customers … Type: Large company Activities: entertainment Technologies: Synthetic Biology | 4 | 0 | 3 | 2,691 | |
Haven House Children's Hospice Our hospice cares for seriously ill children, we are a vital lifeline for families going through the toughest of times. Haven House Children’s Hospice believes that no family should have to face alone the difficulties of looking after a child with a life-limiting condition. We provide a range of services to the child and their families to support them through the most difficult circumstances imaginable. We offer planned respite, short break and end-of-life care, as well as services designed to improve emotional and physical wellbeing, in the hospice and in our local community. Our support includes music therapy, therapeutic yoga, … Type: SMB Activities: healthtech kidtech Technologies: Synthetic Biology | 1 | 0 | 1 | 79 | |
Inmunotek Innovating and sharing ideas since 1992 INMUNOTEK is a pharma company which researches, develops, manufactures and distributes therapeutic vaccines in the fields of allergy, infectious diseases and cancer. In addition, the company develops, manufactures and sells medical devices. INMUNOTEK was founded in 1992 with the mission of improving the quality of life of patients and providing value to healthcare professionals, by creating innovative, safe and effective products. INMUNOTEK's products are sold in both Spain and in more than 50 other countries around the world through our subsidiaries, sales offices and exclusive distributors. Our two production centres are based in the … Type: SMB Activities: deeptech biotech healthtech manufacturing Technologies: Synthetic Biology | 3 | 0 | 3 | 327 | |
Ambiotis Your partner to resolve inflammation Ambiotis is a pre-clinical CRO specialized in the study of inflammatory processes and the active end of inflammation, called resolution. Resolution is now recognized as the necessary biological process to stop inflammation and restore homeostasis in tissues. This recent approach makes possible to study the inflammation process in a completely innovative and differentiating way. Ambiotis proposes services adapted to pharmaceutical, dermo-cosmetic, agro- food/nutraceutical industries to evaluate the potential of their molecules at preclinical or clinical stages of development. Ambiotis thus helps them to put faster on the market more efficient and innovative compounds on immuno-inflammatory … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 1 | 1 | 16 | |
Air Liquide Medical Systems Air Liquide Medical Systems is the subsidiary of Air Liquide Healthcare that is dedicated to Medical Devices. The company develops, manufactures and sells innovative products in three fields: ventilation (ventilators and patient interfaces for intensive care, emergency care, transport, home), equipment for medical gases and aerosol therapy. We engage for people who strive for life, by inventing the easiest to use device and transforming the standards of care. We engage to offer a better quality of life to patients. Our values are: innovation, simplicity, quality, engagement and team spirit. dispositifs médicaux, ventilateurs, and masques Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 8 | 2 | 3 | 404 | |
GCS ACHATS NOUVELLE AQUITAINE [Automatic translation follows] Coordination of regional purchases for health, social and medical-social institutions. 🏆♻ 2023_ Winner of the Purchasing Strategy Award and implementation of CSR in purchasing. [Cristal des Achats] Coordination of regional purchases for health, social and medical-social institutions Purchases, Medical devices, Medicines, Premises maintenance, Food, Helicopter medical transport, Textiles, DASRI, and Periodic technical inspections Type: SMB Activities: healthtech Technologies: Synthetic Biology | 5 | 4 | 1 | 1 | |
Nîmes Sport Santé [Automatic translation follows] Health through Movement Nîmes Sport Santé is an association promoting health through the practice of adapted physical and sports activity. Since its creation in 2002, the association has become a recognized and essential player in sports-health in Nîmes and its region thanks to its actions aimed at people with chronic illnesses, disabilities, or aging... MISSIONS: - Improve health and contribute to the physical, mental, and social well-being of people by having them practice adapted physical activities. - Promote "Sport-Health" as an evaluated, organized, individualized and secure approach, using sport as a tool for health. - Organize, develop … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 6 | |
Urgo Medical Make a difference by helping healthcare professionals heal patients Urgo Medical is the wound-healing division of URGO group. Every day our 1600 employees are passionate about creating, developing and promoting highly innovative dressings and global solutions to heal people suffering from wounds. Our mission, as The Healing Company, is to make a significant difference for patients, healthcare professionals and the healthcare systems. In order to fulfil our mission: • Patient is at the heart of everything we do. • We keep innovating to develop the best in class solutions. • We have a pioneer and entrepreneurial mindset and we dare … Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology | 2 | 1 | 1 | 620 | |
Astellas Gene Therapies Astellas Gene Therapies is an Astellas Center of Excellence developing genetic medicines with the potential to deliver transformative value for patients. Based on an innovative scientific approach and industry leading internal manufacturing capability and expertise, we are currently exploring three gene therapy modalities: gene replacement, exon skipping gene therapy, and vectorized RNA knockdown and will also advance additional Astellas gene therapy programs toward clinical investigation. We are based in San Francisco, with manufacturing and laboratory facilities in South San Francisco and Sanford, North Carolina. Content is intended for a US audience. gene therapy and biotechnology Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 3 | 0 | 2 | 403 | |
Labcorp Drug Development In Pursuit of Answers Clear and confident health care decisions begin with questions. At Labcorp, we’re constantly in pursuit of answers. With unparalleled diagnostics and drug development capabilities, we accelerate innovation and provide insight to improve health and improve lives. Whether you’re a patient, provider, researcher or in the pharmaceutical industry, we’re here for you. More than 70,000 employees strong, we serve clients in more than 100 countries. Labcorp (NYSE: LH) reported revenue of $14 billion in FY 2020. Learn more at www.Labcorp.com Drug Development Services , Toxicology Services, Central Labs, Central Laboratory Services , Clinical Trial Management , CRO … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 5 | 1 | 3 | 9,363 | |
Spirecut The future of hand surgery with ultrasound precision. Spirecut is a Swiss MedTech company. We improve treatments for trigger finger and carpal tunnel syndrome, which affect one in seven in their lifetimes. Our patented Sono-Instruments® leverage ultrasound guidance for incision-less, non-invasive procedures, allowing surgeons to achieve higher precision, lower healthcare costs, and enhance patient recovery outcomes. Spirecut's Sono-Instruments® are CE marked, FDA registered, and now available through a network of local distributors in Switzerland, Belgium, the UK, Ireland, Canada, and the United States. Contact us at info@spirecut.com to learn more. Medtech, Medical devices, Hand Surgery, Carpal Tunnel Syndrome, Trigger Finger, … Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 4 | 0 | 2 | 10 | |
Devicare The Digital Therapeutic Company in Urology Devicare is a specialty biotech company dedicated to develop pathbreaking medical treatments in Urology combining the most recent scientific advances in nutritional therapy with digital technologies. Biotechnology, Medical devices , Digital Health , eHealth, Healthcare, and Digital Therapeutics Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 7 | 0 | 4 | 24 | |
FeedVax Oral vaccines for Aquaculture Oral vaccines for farm animals. We developed a platform of oral vaccine that goes in the feed, easy to use, cost effective for the farmer, zero stress for the animal, without contamination or undesirable effects on the consumer. aquaculture, animal production, climate change, and free of antibiotics Type: Startup Activities: cleantech greentech Technologies: Synthetic Biology | 3 | 1 | 3 | 16 | |
Acurable We create accurate and user friendly wearable medical devices intended to be used by patients at home Acurable is a fast-growing, venture backed MedTech start-up with offices in London and Seville. We create accurate and user-friendly wearable medical devices intended to be used by patients at home. Our award-winning, patented technology enables for the first time the automated diagnosis and management of respiratory conditions. It is the product of more than 10 years’ research at Imperial College London by Acurable’s founder, Professor Esther Rodriguez Villegas, and has been recognised as a breakthrough in respiratory medicine, winning some of the most … Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 4 | 0 | 4 | 28 | |
Peptone Drugging disordered proteins with physics and AI Peptone is a therapeutics company that uses AI and an experimental physics product engine to design small molecules targeting the 6,200 intrinsically disordered human proteins that Alpha Fold 3 cannot model. artificial intelligence, structural biology, high performance computing, supercomputers, biotechnology, and intrinsically disordered proteins Type: Startup Activities: biotech deeptech it services Technologies: Synthetic Biology | 46 | 4 | 46 | 40 | |
The EVERY Company Accelerating The World’s Transition To Animal-Free Protein. 🥚🚀 The EVERY Company combines industry-leading expertise in food technology and flavor to enable the foods of tomorrow, today, for the world’s global food and beverage industries. We’re creating game-changing solutions for businesses and brands, with our people and products delivering leveled-up performance, unprecedented outcomes in taste and texture, and animal-free innovation to a host of categories, in line with consumer trends. Along the way, we’re co-creating a better tomorrow, commercializing nutritious, nature-equivalent animal proteins from fermentation that taste and function like the originals, while using significantly less land, water and greenhouse gas … Type: Startup Activities: agritech healthtech Technologies: Synthetic Biology | 16 | 3 | 11 | 134 | |
Desktop Genetics Powering the genome editing revolution with AI-driven design and analysis for cell therapy and drug discovery. Desktop Genetics is an international company established in 2012 to help researchers discover and treat the root genetic causes of human disease. Today, Desktop Genetics is a recognised leader in genome editing technology, staffed by dedicated team of genome editing experts, bioinformaticians and data scientists, driven by the real-world impact of CRISPR technology. We have invested four years developing our core technology, DESKGEN AI, trained on the largest database of genome editing data in the world. DESKGEN AI powers our flagship DESKGEN CRISPR Library … Type: Startup Activities: biotech deeptech Technologies: Generative A.I. A.I. A.I. - Machine Learning Synthetic Biology | 2 | 1 | 0 | 0 | |
Surface Oncology Inc. #lifeunderthesurface #BBJBestPlacesToWork2023,2022,2021 #BostonGlobeTopPlacesToWork2023,2022,2021 Surface Oncology is a clinical-stage immuno-oncology company focused on using its specialized knowledge of the biological pathways critical to the immunosuppressive tumor microenvironment (TME) for the development of next-generation therapies to help patients suffering with cancer. Recent advances in understanding how the immune system fights cancer has created a first wave of immunotherapies with profound benefits for some patients. These first-generation therapies, or "checkpoint inhibitors", have been groundbreaking, but only a relatively small subset of patients is deriving long-term benefit. We believe that the lack of a broad and sustained clinical response is because these first-generation therapies … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 1 | 0 | 14 | |
PVA Med All the Tools You’ll Need to Fabricate Devices In-House. PVA Med offers intuitive 3D printing and digital solutions to orthotists and prosthetists worldwide. We provide the tools, training, and support for O&P practices to incorporate digital workflows into their current patient care. Modernizing your practice creates stress. We create solutions. Please contact us for more information at med@pva.net or +1 518 371-2684. Prosthetics, Prosthetic Covers, 3D Printing, cadcam, orthotics, 3D Printers, and Training Type: Startup Activities: deeptech healthtech Technologies: 3D Printing Synthetic Biology | 0 | 0 | 0 | 5 | |
Agios Pharmaceuticals Where science meets heart. Passionately committed to transforming the lives of people with genetically defined diseases. Agios is a biopharmaceutical company that is fueled by connections. We are passionately committed to applying our leadership in the field of cellular metabolism to create life-changing therapies for people living with rare diseases. The bonds we build with patient communities, healthcare professionals, partners and colleagues help elevate our thinking and propel our science to new heights. These connections, combined with our cellular metabolism expertise, have fueled the development and approval of our first-in-class pyruvate kinase (PK) activator, as well as other investigational therapies. … Type: Startup Activities: biotech healthtech deeptech Technologies: Synthetic Biology | 8 | 2 | 3 | 587 | |
GenEdit Delivering the potential of genetic medicines GenEdit is focused on overcoming the major challenge to genetic medicines: Delivery. We aim to overcome this limitation and enable treatment of a broad range of diseases, having a positive impact on the lives of as many people as possible. The foundation of our company is our NanoGalaxy platform. NanoGalaxy contains a library spanning thousands of unique non-viral, non-lipid, polymer nanoparticles. Using our iterative screening process, we are able to identify polymer nanoparticles that can deliver the needed genetic medicine payload to the needed tissue to treat disease. We are focusing our research on … Type: Startup Activities: biotech deeptech nanotech Technologies: Synthetic Biology | 0 | 0 | 0 | 47 | |
Luminopia Pioneering a new class of treatments for significant neuro-visual disorders. Luminopia is pioneering a new class of treatments for significant neuro-visual disorders. Luminopia is committed to creating digital therapeutics that are both rigorously evaluated for FDA approval and genuinely engaging for patients. As an Innovation Partner of Boston Children’s Hospital, the company is developing its lead product to treat amblyopia, the leading cause of vision loss among children. For more information, visit luminopia.com. Please see Luminopia Directions For Use for more information: luminopia.com/dfu digital health, healthtech, amblyopia, lazy eye, ophthalmology, and neuroscience Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 28 | |
Modern Meadow Where Natural Inspiration Meets Extraordinary Innovation Modern Meadow is a purpose-driven company positioned at the intersection of material science and biology with a mission to be a catalyst for real-world impact on people and the planet. Modern Meadow’s proprietary Bio-AlloyTM and Bio-F@rmTM technology application platforms harness the unique properties of tuned proteins to sustainably move the world away from petrochemical and animal-derived inputs without compromising on performance. These innovations can drop into any existing infrastructures for immediate scalable adoption in the materials, beauty, and other industries. Our close relationship with development partners and production facilities allows companies partnering with Modern … Type: Startup Activities: biotech deeptech Technologies: New Materials Synthetic Biology | 8 | 4 | 3 | 72 | |
Virpax Pharmaceuticals Inc. (Nasdaq:VRPX) Collaborating with NIH & DoD to develop treatment options, targeting unmet needs in three multi-billion dollar markets. Virpax is pioneering advanced healthcare solutions with Probudur, its flagship product leveraging proprietary liposomal encapsulation. Designed for sustained release, Probudur delivers local anesthetic at the wound/incision site, effectively managing post-operative pain for an extended 96 hours. Collaborating through Cooperative Research and Development Agreements (CRADA) and partnering with prestigious institutions like the National Institute of Health/NCATS and U.S. Army Institute of Surgical Research/Department of Defense, we are committed to developing non-addictive treatments. Additionally, our involvement in the Epilepsy Therapy Screening Program (ETSP) underscores our … Type: Startup Activities: biotech deeptech healthtech manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 10 | |
Forma Therapeutics Dedicated to transforming the lives of patients with rare hematologic diseases and cancers. Forma Therapeutics (Nasdaq: FMTX) is a clinical-stage biopharmaceutical company focused on the research, development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers. Our R&D engine combines deep biology insight, chemistry expertise and clinical development capabilities to create drug candidates with differentiated mechanisms of action focused on indications with high unmet need. Our work has generated a broad proprietary portfolio of programs with the potential to provide profound patient benefit. We aim to create futures for patients, their families … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 161 | |
Pyxis Oncology Charting a course to therapeutics for difficult-to-treat cancer. Pyxis Oncology is transforming the lives of patients with cancer by advancing our differentiated portfolio of biologics that specifically target tumor cells and overcome immune suppression. We believe that antibody-drug conjugates (ADCs) and immunotherapies have the potential to address difficult-to-treat cancers and improve patient outcomes. Immuno-oncology and oncology Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 3 | 1 | 2 | 65 | |
BLACKROLL AG Do it your health. We offer people of all ages and sports levels the possibility to improve their flexibility, balance, and strength by doing simple exercises and applying self-massage. We create the ideal tools to complement traditional treatment methods and make fascia- and functional training available to all. Train, release and restore - all in one. - - - In 2007, BLACKROLL® was developed in Germany by Jürgen Dürr. As of 2012, BLACKROLL® firmly established itself on the market, and got well supported and recommended by leaders in the health - sports and therapeutic industry. In the autumn of 2013 … Type: Startup Activities: healthtech Technologies: Synthetic Biology | 3 | 1 | 3 | 108 | |
AFAR [Automatic translation follows] Continuing education for healthcare professionals since 1980 Since 1980, Afar has been training professionals in public and private healthcare institutions, social and medico-social institutions, local authorities and businesses. Now recognized as one of the main players in training in these sectors, Afar continues its commitment to professionals by offering expertise in the fields of management, health and safety at work, mental health, disability and mediation. In line with the objectives of national and regional health programs, our training activities and CPD programs welcome more than 5,600 trainees per year, from more than 500 clients spread across the … Type: SMB Activities: edtech healthtech Technologies: Synthetic Biology | 5 | 1 | 4 | 103 | |
NEOMED Services [Automatic translation follows] Your asset in design validation and regulation of medical devices Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 1 | |
EURAXI Conception et réalisation de vos projets d'Etudes Cliniques, Registres, Programmes d'Accès précoces, Home Nursing 🚀✨ Euraxi (CRO) is a project management specialist in the health sector, assisting clients with their projects since 1986. Our organisation and service offer have been perfectly tailored to meet the precise needs of our clients. We can take on all or part of your operations thanks to our multidisciplinary team. This team is organised into specialised units and is guided by the risk management and quality procedures inherent to the requirements of your projects. - Clinical Operations - Data Management, eTools & Statistics - Medical … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 2 | 1 | 2 | 118 | |
ILIFE CONSULTING A reliable partner for clinical development, we synchronize endpoints with funding milestones, ensuring impactful trials 🤝 ILife Consulting is an entrepreneurial clinical partner specializing in providing tailored support for innovative, emerging life science companies. With about 20 active clients, including prominent Biotech companies and prestigious clinical sites such as Imcheck, Peptinov, Carthera, Smart Immune, Gustave Roussy, and Surgimab, who rely on our expertise, we are committed to making your clinical development genuinely fit for your purpose. We create tailored plans for each partner based on their specific needs, including study design, budget planning, and financing strategies. Our strength lies in … Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 4 | 0 | 3 | 21 | |
Bionest Partners Bionest Partners is a global consulting firm focused on Pharma, Biotech, Medical Device and Diagnostics that helps clients navigate complex product development issues in order to drive growth, create value and gain competitive advantage. We also offer our expertise and analytic skills to support investors with due diligence assignments in these markets. Bionest consultants are valued strategic partners who have helped more than 250 companies around the world build high-value product portfolios, optimize development approaches and prepare for commercial success. Our track record includes more than 500 successful projects consisting of innovative, creative and differentiated action plans grounded in in-depth … Type: SMB Activities: healthtech biotech deeptech consulting Technologies: Synthetic Biology | 2 | 0 | 2 | 34 | |
Panacee Healthcare & Life Sciences communication agency Panacee is a communication agency specialized in health market. We deal with the main stakeholders of life sciences and medical area; #biotech, #medtech, #mhealth, #publichealth, #pharma Communication, Marketing, Santé, Scientifique, Sciences de la vie, Médical, Biotech, medtech, pharma, medical devices, Santé publique, identité visuelle, Digital, Print, réseaux sociaux, BtoB, professionnels de santé, chercheurs, and patients Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 10 | 1 | 9 | 16 | |
FYTEXIA Fytexia is a life science company that specialises in developing scientifically-supported active ingredients for dietary supplements. Fytexia’s mission is to reduce the risk factors associated with conditions affecting overall quality of life. We achieve this by offering innovative nutritional ingredients backed by scientific research and public health recommendations. Fytexia’s innovation team collaborates with a global network of scientific researchers to develop functional ingredients that undergo rigorous scientific scrutiny, from characterising the active compounds to clinically demonstrating their benefits. Fytexia's ingredients increase the value of the most advanced health products, contributing to the wellbeing of consumers, worldwide. Fytexia is part of … Type: SMB Activities: healthtech foodtech deeptech Technologies: Synthetic Biology Bio sourced materials | 1 | 0 | 1 | 48 | |
Mayoly [Automatic translation follows] Taking care to heart Through its subsidiaries, Mayoly is a family-owned, independent, French pharmaceutical and dermatological laboratory with an international footprint. For more than a century, it has successfully been growing its business with a focus on Gastroenterology and Dermocosmetics. Our French industrial heritage relies on our values of Responsibility, Pragmatism and Caring. We strive passionately and tirelessly to provide patients and people with the best possible healthcare daily, and aim to establish ourselves as a leader in Consumer Healthcare over the coming decades Our know-how applies to several therapeutic areas, such as gastroenterology, rheumatology, ENT, general … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 9 | 1 | 3 | 1,012 | |
Solventum Medical Helping you achieve positive outcomes for your patients The world needs you at your best, so we create breakthrough solutions that help you save valuable time and restore patients' lives. Medical products and solutions, Dental and orthodontic supplies, and Health information solutions Type: SMB Activities: healthtech Technologies: Synthetic Biology | 14 | 2 | 8 | 9 | |
GeneCode GeneCode is a private pharmaceutical development company focused on the development of disease-modifying therapeutics to combat neurodegeneration. The GDNF Mimetics platform leverages the disease-modifying properties of GDNF to small molecules with drug-like properties. R&D-wise, GeneCode has remarkably improved the properties of the identified hits, making them more active and effective, drug-like and better show their ability to combat neurodegeneration in Parkinson ́s disease (PD). Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 3 | |
Natera We are a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. NateraTM is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that lead to longer, healthier lives. Where some set out to build a test, we set out to achieve a mission: change the management of disease worldwide by using DNA testing to proactively inform treatment. Through a cfDNA … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 2 | 1 | 3,811 | |
Medical Design & Outsourcing Medical Design & Outsourcing focuses on all aspects of the design, development and manufacturing of medical devices. Medical Design & Outsourcing covers the technical advances fueling innovation in the design, development and contract manufacturing aspects of medical devices and equipment. In addition to posting several staff-written stories per day, we publish an edition seven times a year with themes such as leadership in medtech, enabling technologies, hot topics, contract manufacturing, women in medtech, the medical device equipment handbook and the Big 100, (an in-depth look at the largest 100 medtech/medical device companies in the world). The editions include staff-written features … Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 9 | 0 | 6 | 4 | |
Ed'Innov Santé Custom-made accompaniment Ed' Innov Saté is a custom training organization, a public health project consulting firm and a creative agency. Ed' Innov Santé supports teams in the optimization of their Care Paths but also in the creation or optimization of Therapeutic Patient Education programs. As a leader in these themes, Ed' Innov santé has, to date, supported more than 250 health establishments with an innovative and highly differentiating approach in Metropolitan France, French overseas departments and territories and French Polynesia (projects in Africa to come). Ed' Innov Santé is an independent organization, regardless of the source of funding, with an … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 4 | 0 | 4 | 3 | |
Clinique de l'Escrebieux [Automatic translation follows] We take care of you. The Clinique de l'Escrebieux is a private 95-bed facility that opened its doors in December 1997. Located 5 km from Douai, it is in the heart of the Artois Territory and mainly welcomes patients from the Nord Pas-de-Calais region. It is focused on treating anxiety and depressive disorders in adults, men and women, and on treating psychiatric disorders in people over 65 years old. For this purpose, a new unit, which welcomed its first patients in the summer of 2015 and dedicated to geriatric psychiatry, was entirely created. In September 2009, it … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 2 | 1 | 1 | 17 | |
OMéDIT Centre-Val de Loire [Automatic translation follows] Observatory of Medicines💊, Medical Devices💉, Therapeutic Innovations🧬 🔎 OMéDIT Centre-Val de Loire is a regional structure for support, evaluation and independent scientific expertise, placed with the ARS. It is strongly committed to supporting and implementing quality, safety and medico-economic efficiency approaches related to medicines and medical devices, for patients and healthcare professionals. In charge of coordinating a coordinated policy on the proper use of health products and good practices, OMéDIT participates in the fight against avoidable iatrogenic diseases: ➡️ by disseminating all information on the proper use of health products to all health professionals involved in the … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 11 | 2 | 7 | 8 | |
UGECAM PACA et Corse [Automatic translation follows] • UGECAM Group: - 1st private non-profit healthcare operator - involved in the areas of follow-up and rehabilitation care - 225 establishments, 14,500 beds and places, and 13,500 professionals. - 13 regional departments, each managing around twenty health and/or medico-social establishments in France • UGECAM PACA Corse: - presence in 6 departments - quality care offer, as close as possible to the needs of the population - 6 specialized health establishments for Continuing Care and Rehabilitation (SSR) - 20 medico-social structures for children and adults with motor and/or mental disabilities - recognized health player - preservation and … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 9 | 2 | 8 | 465 | |
OMEDIT Nouvelle-Aquitaine Guadeloupe Guyane [Automatic translation follows] Observatory of Medicine, Medical Devices and Therapeutic Innovation OMEDIT Nouvelle-Aquitaine Guadeloupe and Guyana is a support and expertise structure participating in the Regional Vigilance and Support Network (RREVA), for the proper use of medicines and medical devices. This regional structure with medico-economic skills provides support for the development of contracts for improving the quality and efficiency of care (CAQES) Type: SMB Activities: healthtech Technologies: Synthetic Biology | 6 | 2 | 6 | 19 | |
Centre hospitalier Métropole Savoie - CHMS [Automatic translation follows] The CHMS is located in Chambéry and Aix-les-Bains. It is the support facility for the GHT Savoie/Belley. A reference facility for the Savoie Belley area, the Métropole Savoie hospital center is located on two sites in Chambéry and Aix-les-Bains. Each year, the two adult emergency departments, the pediatric emergency department and the gynecological emergency department receive more than 94,000 patients 24 hours a day. The Emergency department includes the only adult intensive care unit in the area. Its recent technical platform allows almost all diagnostic and therapeutic procedures to be performed. All types of surgery are performed, … Type: SMB Activities: healthtech Technologies: SaaS Synthetic Biology | 5 | 4 | 1 | 748 | |
Centre de Santé Mentale Angevin (CESAME) [Automatic translation follows] Public mental health institution - Maine-et-Loire, Pays de la Loire A public mental health institution, CESAME provides psychiatric care to children, adolescents and adults. The institution is organized into sectors covering the department of Maine-et-Loire, with the exception of the population of the districts of Cholet and Saumur. Each psychiatric sector has, apart from full hospitalization, several places of care distributed throughout its territory: Medico-Psychological Center (CMP), Part-Time Therapeutic Reception Center (CATTP), day centers or hospitals, therapeutic apartments, permanent locations... At the heart of this system, the CMP occupies a special place. Psychiatry, Outpatient, Care, Medicine, Medico-Psychological … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 6 | 1 | 6 | 277 | |
MANDALA International REGULATORY AFFAIRS SPECIALISTS AND REGISTRATION HOLDER MANDALA International offers consulting and operational support for healthcare-related companies seeking to develop their business in Latin America with a special focus on Brazil, Mexico and Colombia. Apart from this, we provide support for CE mark to enter European countries. MANDALA International is the world’s leader for Medical Device & Pharmaceutical Registration in Brazil (ANVISA), Mexico (COFEPRIS), Colombia (INVIMA) and Europe (CE). It is the only service provider authorized to import and distribute drugs in Brazil (Brazilian Registration Holder) and to run an ANVISA-approved laboratory to register pharmaceuticals. MANDALA specializes in the healthcare industry … Type: SMB Activities: deeptech healthtech regtech Technologies: Synthetic Biology | 0 | 0 | 0 | 21 | |
OMéDIT Normandie [Automatic translation follows] Observatory of Medicines, Medical Devices and Therapeutic Innovations OMéDIT Normandie is a regional structure for support, evaluation and independent scientific expertise, placed with the ARS. It is strongly committed to supporting and implementing quality, safety and medico-economic efficiency approaches related to medicines and medical devices, for patients and health professionals. Type: SMB Activities: healthtech Technologies: Synthetic Biology | 6 | 1 | 6 | 4 | |
CureMatch, Inc. AI-based Precision Medicine Decision Support for Oncology CureMatch is a leader in AI-based precision medicine, digital decision support solutions that support cancer treatment. Created to empower oncologists with world-class research and sophisticated AI algorithms, the CureMatch Decision Support System assists the doctor with understanding therapeutic options that are personalized to the unique molecular profile of the individual patient’s tumor. digital health, oncology, decision support software, AI, precision medicine, and combination therapy Type: Startup Activities: healthtech deeptech biotech Technologies: A.I. Synthetic Biology | 5 | 1 | 4 | 26 | |
Sisu Global Designing & commercializing medical devices for all healthcare ecosystems. Sisu Global develops patented, cutting-edge, world-class medical devices that are designed to save lives, enable patient access to care and increase resources for healthcare ecosystems. Our medical device, Hemafuse, is a highly effective, mechanical alternative to donor blood and available in Ghana, Kenya, India, and Tanzania. Hemafuse increases access to blood by enabling clinicians to capture a patient’s blood, filter it, and return fresh, whole blood back to that same patient. Hemafuse provides immediate access to blood transfusion across trauma, obstetric, general, and orthopedic surgeries with internal bleeding. We have raised … Type: Startup Activities: deeptech healthtech civictech Technologies: Synthetic Biology | 8 | 2 | 8 | 9 | |
Ikena Oncology Patient-directed oncology therapies across pathways relevant in tumor and immune cells Ikena is a targeted oncology company focused on developing novel cancer therapies targeting key signaling pathways that drive the formation and spread of cancer. Our programs focus on key cancer driver pathways that are well-validated in scientific literature but lack approved or effective therapies and therefore have the potential to address high unmet medical needs. By leveraging our deep understanding of discovery chemistry, translational science, and patient-centric drug development, we have built a deep pipeline of wholly owned and partnered programs focused on genetically defined or biomarker-driven cancers, which … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 5 | 0 | 5 | 23 | |
UNYQ For everybody, for every body #likenoother UNYQ with headquarters in San Francisco with global reach creating products for prosthetics or what we call UNYQ Wears. We create industry-leading, data and biometrical designed wears, reimagining medical devices using 3D printing to create products that heal you or reflect you. UNYQ uses emerging technologies and creates next-generation of wears that are simultaneously aesthetically beautiful yet practical and functional, our wears living close to our customers every day. Our first line of wears was a range of prosthetic covers for upper and lower limb amputees. These covers offer amputees personalization (colors and style), … Type: Startup Activities: deeptech healthtech fashtech Technologies: 3D Printing A.I. Synthetic Biology | 4 | 2 | 0 | 31 | |
Hound Labs, Inc. SAFETY + FAIRNESSTM Hound Labs, Inc. develops advanced breath testing technologies to address leading public health and safety issues. The Company’s flagship product, the HOUND® CANNABIS BREATHALYZER, introduces the drug testing industry’s shortest cannabis detection window, giving employers a practical and objective solution to detect and deter recent use. The ultra-sensitive, analytical test identifies active THC molecules in breath, limiting cannabis detection to the workday. As cannabis legalization increases employee access to THC, employers are seeking a solution to continue testing for the drug while balancing workplace safety with employee fairness and privacy. Hound Labs’ groundbreaking innovation returns an objective … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 36 | |
Pharmap [Automatic translation follows] Your Pharmacy products, delivered to your home in 60 minutes Pharmap is the leading pharmaceutical home delivery solution in Italy that allows you to receive any Pharmacy product (including prescription drugs) in 1 hour, or in the preferred time slot. The service, born in 2016, now has over 400,000 users in more than 1,000 municipalities in Italy (including Milan, Rome, Genoa, Bologna, Florence, Turin, Palermo, Cagliari). More than 2,500 pharmacies manage home deliveries for their customers through Pharmap. In 2019, Pharmap entered the ranks of the 50 most innovative scale-ups in Italy. Delivery, Pharmacy, and Pharmaceutical products Tags: H2020 Type: Startup Activities: consumer services Technologies: Synthetic Biology | 2 | 0 | 1 | 47 | |
Neuromod Devices A pioneer in the development of bimodal neuromodulation treatments Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation. We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control of their own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle. Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and … Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 4 | 0 | 3 | 63 | |
MiNA Therapeutics Activating RNA, mastering disease Harnessing an innate mechanism of gene activation, MiNA Therapeutics' platform enables the development of new medicines that restore normal function to patients’ cells. We are applying our technology and clinical know-how to transform the therapy landscape of severe liver and other diseases. Gene activation, RNA therapeutics, Liver disease, and Drug discovery Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 4 | 1 | 4 | 34 | |
QuantuMDx Transforming Point of Need Multiplex Diagnostics QuantuMDx is a progressive MedTech company passionate about creating multiplex molecular diagnostic solutions for use at the point of need. MedTech, Molecular Diagnostics, Multiplex Molecular Diagnostics, Point of Care, Point of Need, COVID-19, Medical device, Diagnostic device, DNA extraction, TB, Sepsis, Transcriptomics, PCR, Microarray, Assay Development, Assay Feasibility, Rapid Diagnostics, Respiratory Infections, Sexually Transmitted Infections, Host Response, and In vitro Diagnostics Type: Startup Activities: deeptech nanotech biotech healthtech Technologies: Synthetic Biology | 8 | 0 | 7 | 97 | |
MyCognition Changing the world one mind at a time MyCognition has developed NHS approved apps that assess and promote brain health through cognitive fitness. The apps are CE Marked (class 1A medical device) and recently we obtained a prestigious UCL award for our research. Our apps work on all devices, in all settings, are self-administrated and provide insightful reports and automatically assess to personalise cognitive training. They work in people of all ages, gender and health states. MyCognition enhances brain health and performance through the use of our cognitive fitness assessment and training programmes, which are self-administered, easy to access and … Type: Startup Activities: healthtech Technologies: Synthetic Biology | 7 | 1 | 1 | 1 | |
Cellomatics Biosciences Ltd Our expertise, Your discovery Cellomatics Biosciences Ltd. (www.cellomaticsbio.com) is a laboratory-based Contract Research Organisation (CRO) specialised in Oncology/Immuno-Oncology, Immunology/Inflammation and Respiratory therapeutic areas. Based at Colwick Quays Business Park, Nottingham UK, our experienced scientific team offers bespoke and innovative preclinical in vitro bioassay services to support our client’s drug development programmes. We work with diverse group of global clients including early start-ups, virtual/small to medium sized Biotechnology and Pharmaceutical companies. Multiplex Immunoassay, Target and biomarker validation, In vitro functional assays, Molecular Biology, Receptor binding, Toxicity testing, Immuno-Oncology, Oncology, Immunology, Inflammation, and Respiratory Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 0 | 18 | |
Exscientia Better drugs, faster Exscientia is a global pharmatech company using patient-first artificial intelligence (AI) to discover better drugs, faster. Our mission is to encode, automate and transform every stage of the drug design and development process, by combining the latest AI techniques with experimental innovation, to enable the design of patient centric drug candidates with an improved probability of success. Our validated platform has delivered the first three AI-designed drugs to enter clinical trials and is the first AI system proven to improve clinical outcomes in oncology. We’ve significantly accelerated pre-clinical drug discovery, with 10x productivity improvement in delivering a … Type: Startup Activities: biotech deeptech manufacturing Technologies: A.I. Synthetic Biology | 8 | 3 | 5 | 410 | |
Biogelx We design and supply artificial tissue environments for cell culture & bioprinting applications. Biogelx is helping people work in translational science, drug discovery and tissue engineering by 'making in vitro cell cultures more in vivo'. We do this through manufacturing and supplying 3D cell cultures that can be tuned to specific tissues and synthetic bio-inks that are reproducible, scalable, easy to handle and suitable for clinical decision making. Our portfolio of biomaterials is comprised of synthetic peptide hydrogels that act as extracellular-matrix environments to support cell growth. In addition, the chemical and physical properties of our biomaterials can be precisely … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 0 | 0 | 2 | |
Open Bionics Turning disabilities into superpowers Open Bionics: Open Bionics is a prosthetics company developing affordable, assistive devices that enhance the human body. We've started by introducing the Hero Arm, a stylish multi-grip bionic arm. Current upper limb prostheses exist as hooks, grippers, or expensive bionic hands. We're on a mission to make beautiful bionic limbs more accessible. Aged 17, Joel Gibbard began tinkering with robotic hands. There was something about the movement of a disembodied humanoid hand that captured his imagination. Hundreds of prototypes and many crates of failures later, in 2014, Joel co-founded Open Bionics with Samantha Payne. With the … Type: Startup Activities: deeptech healthtech manufacturing Technologies: Robotics Synthetic Biology | 12 | 5 | 2 | 50 | |
Mogrify Transforming the lives of patients with degenerative diseases through a novel class of in vivo reprogramming therapies. Mogrify® has developed a proprietary suite of platform technologies that utilize a systematic big-data approach to direct cellular reprogramming (Rackham et al., Nature Genetics, 2016) and the maintenance of cell identity (Kamaraj et al., Cell Systems, 2020). The platforms, MOGRIFY® and epiMOGRIFY®, developed over a 12-year period via a multi-national research collaboration, deploy next-generation sequencing, gene regulatory and epigenetic network data to enable the prediction of the transcription factors and growth factors required to produce any target human cell type from any source … Type: Startup Activities: deeptech biotech Technologies: A.I. A.I. - Machine Learning Synthetic Biology | 9 | 0 | 7 | 39 | |
GrainSense GrainSense has developed NIR solutions for instant grain quality testing. Learn more: www.grainsense.com A Nordic innovation transformed traditional, bulky Near-Infrared (NIR) spectroscopy equipment into a convenient format to help agribusinesses with instant grain quality tracking. Handheld GrainSense Analyzer uses (NIR) spectroscopy technology found in laboratory instruments – in a battery-powered, handheld device. You get reliable protein, moisture, oil and carbohydrate contents in seconds from just a few kernels. The GrainSense Flow Analyzer has been developed for analyzing real-time grain quality in an environment where grains are actively flowing. Whether installed in an elevator of a combine harvester or in a … Type: Startup Activities: agritech Technologies: Synthetic Biology | 0 | 0 | 0 | 16 | |
Sooma Medical Depression treatment at home. Transforming psychiatric and neurological care with accessible therapies. Sooma Oy is developing, manufacturing and marketing a non-invasive therapy devices for neurological and psychiatric disorders (depression and chronic pain). Sooma uses transcranial direct current stimulation (tDCS) technology. Our technology is trusted by over 150 clinics worldwide. We feel that everyone deserves high quality care. With our Sooma therapies, we want to provide an effective and safe way to treat disorders within psychiatry and neurology. We want to offer a safe, drug-free treatment option with minimal side effects, that minimises any discomfort that might otherwise come with treating … Type: Startup Activities: healthtech deeptech biotech manufacturing Technologies: Synthetic Biology | 7 | 0 | 6 | 24 | |
Thuasne Wings for you health Fondé en 1847, Thuasne® imagine, développe et fabrique des dispositifs médicaux permettant à chacun de devenir acteur de sa propre santé. Depuis 6 générations, le Groupe propose des solutions de santé concrètes, adaptées et innovantes dans les domaines de l’orthopédie, de la compression médicale et du sport. L'entreprise, avec 2 400 collaborateurs, a réalisé un chiffre d’affaires de 281 millions d’euros en 2023 dont 50 % à l’international. Le Groupe est aujourd’hui présent dans 110 pays notamment par l’intermédiaire de ses 19 filiales en Europe, en Amérique du Nord, en Asie et en Afrique. www.thuasne.fr Founded … Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 25 | 14 | 10 | 636 | |
Medincell Better Medicine For All Better Medicine for All MedinCell is a pharmaceutical company at commercial stage. We develop a portfolio of long-acting injectables in various therapeutic areas. Our proprietary technology BEPO® aims to ensure patient compliance, improve the effectiveness and accessibility of treatments, and reduce their environmental footprint. We collaborate with tier-one pharmaceutical companies and foundations to improve Global Health through new therapeutic options. Our mission is to contribute to the improvement and protection of the health of populations across the world. The fair sharing of the value created with all our employees is the foundation of our business model. … Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 20 | 4 | 11 | 148 | |
Innov'Pulse InnovPulse is a medical devices company based out of France. Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 4 | 3 | 1 | 2 | |
GOBIO - Europe Technologies [Automatic translation follows] Operator Assistance Solutions - Exoskeletons and Zero Gravity Arms The GOBIO team comes from the industrial world and meets the needs of customers based on the latest mechanical or cobotics technologies, which it adapts to their uses. The team thus develops a complete range of operator assistance devices with: - ergoskeletons and exoskeletons - articulated zero gravity arms These solutions meet the different needs of companies in terms of industrial or logistics applications. An innovative team, GOBIO provides an individualized response to professionals who are keen to improve the working conditions of their employees. exoskeleton, ergoskeleton, zero … Type: SMB Activities: industry 4.0 Technologies: Synthetic Biology | 16 | 4 | 13 | 5 | |
ABL ABL Europe is now part of the OXB Group More info at : oxfordbiomedica.com ABL Inc remains part of the Institut Mérieux Group More info at ablinc.com Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 5 | 5 | 2 | 503 | |
Impeto Medical SUDOSCAN - Early detection and follow-up of autonomic neuropathy Impeto Medical SAS markets SUDOSCAN, a Class IIa Medical device regulated under the CE certification. Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology | 2 | 1 | 0 | 24 | |
Gene Therapy Program | University of Pennsylvania Catalyzing the development of transformative genetic-based therapeutics from concept to clinic. Dedicated to discovery + translational research and led by Dr. James Wilson, the Gene Therapy Program (GTP) at the University of Pennsylvania focuses on the development of next-generation gene transfer vectors and their application in the treatment of a variety of acquired and inherited diseases. Dr. Wilson's commitment to patients with rare diseases stems from his days as a graduate student and medical student at the University of Michigan between 1977 and 1984. He was discouraged by the lack of available treatments for rare disease patients, but optimistic that … Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 1 | 1 | 0 | 78 | |
Scout Bio Shaping the future of veterinary medicine through one-time therapies for major chronic pet health conditions. Scout’s mission is to harness the genetic revolution transforming human medicine to deliver the future of veterinary medicine. By combining world-leading talent in animal health and gene therapy technology, we have built a development platform for one-time therapies that address major areas of unmet medical need in pet medicine. We are a global company supported by leading life sciences investors and an R&D collaboration with the renowned Gene Therapy Program at the University of Pennsylvania. About Our Currently Enrolling Study for Cats Scout’s first therapy … Type: Startup Activities: deeptech biotech pettech Technologies: Synthetic Biology | 1 | 1 | 0 | 16 | |
Exothera Best-in-class viral vector and nucleic acid development and manufacturing services Exothera is a contract research, development, and manufacturing organization (CDMO) dedicated to viral vector and nucleic acids production. As a technology-driven company, Exothera provides best-in-class bioprocessing expertise that capitalizes on the best and most innovative manufacturing technologies developed within the Univercells group. The company delivers accelerated discovery services as well as process development/optimization to rapidly reach GMP clinical and commercial production of viral vectors and nucleic acids. At Exothera and Univercells, Our mission is to make life-changing therapies available to all. As a Univercells company, Exothera capitalizes on novel manufacturing … Type: Startup Activities: deeptech biotech manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 165 | |
MSD Animal Health UK Ltd Please view our Community Guidelines, https://www.msd-animal-health.co.uk/social-media MSD Animal Health is the global animal health business unit of MSD. Through our commitment to the Science of Healthier Animals®, we offer veterinarians, farmers, pet owners and governments one of the widest ranges of veterinary pharmaceuticals, vaccines and health management solutions and services as well as an extensive suite of digitally connected identification, traceability and monitoring products. We are dedicated to preserving and improving the health, welfare and performance of animals and the people who care for them. Type: Startup Activities: healthtech pettech Technologies: Synthetic Biology | 0 | 0 | 0 | 220 | |
Phibro Animal Health Poland [Automatic translation follows] Healthy Animals. Healthy Food. Healthy World Phibro Animal Health is a leading global manufacturer of diversified veterinary and mineral feed supplements, headquartered in Teaneck, New Jersey (USA) with offices around the world. We operate in over 30 countries, supporting the development and achievements of our customers. We continuously research, develop, produce and sell innovative medicinal products, in particular technologically advanced vaccines for poultry, which are our main specialization. In 2012, Phibro entered the European dairy cattle nutrition market. Today, we offer two main products: OmniGen and Animate, but our goal is to continue to expand the portfolio … Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 6 | |
Medical Detection Dogs Dogs Saving Lives We train dogs to help the NHS and save lives Medical Detection Dogs works with the powerful scenting ability of dogs. We train them to detect the odour of diseases like cancers, Parkinson’s disease, malaria and potentially fatal bacterial infections, as well helping people with complex, life-threatening medical conditions stay safe and lead more normal, independent lives. Our Medical Alert Assistance Dogs save lives daily by alerting their human partners to an odour change which indicates an oncoming, potentially fatal medical event. Conditions W have trained dogs to alert to include Type 1 diabetes, PoTS, Addison’s disease … Type: Startup Activities: deeptech healthtech biotech pettech Technologies: Synthetic Biology | 1 | 1 | 0 | 64 | |
LAPROVET [Automatic translation follows] Their health is also ours. LAPROVET is a leading French veterinary laboratory in sub-Saharan Africa and with strong growth in Southeast Asia and the Middle East. With our ambition to contribute to the long-term development of livestock sectors, the company has grown and developed by putting its values at the forefront: - Quality with the manufacture of veterinary medicines according to current European standards (GMP, GLP and GDP). - Education for local support and ongoing training of breeders in the field thanks to an efficient network of national technical representatives The nature of human relationships within our … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 1 | 1 | 1 | 27 | |
Bioproperties Pty Ltd Research company, GMP manufacturer & global supplier of live vaccines to the intensively farmed food animal industry. Bioproperties Pty Ltd is a leading Australian novel vaccine research company (Melbourne), GMP manufacturer (Sydney) and global supplier of live vaccines to the intensively farmed food animal industry. Type: SMB Activities: foodtech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 91 | |
MabGenesis Inc. Discovery of innovative therapeutic antibodies for human and animal health MabGenesis Inc. is a biopharmaceutical company that provides fully species-specific therapeutic antibodies to human and companion animals. We have the world’s highest quality antibody libraries (MOURA Libraries) in terms of functionality and completeness, as well as highly efficient monoclonal antibody isolation technology (IMPACT). By using these, we make it possible to obtain high-affinity monoclonal antibodies that recognize unique 3D structures or subtle structural differences of target molecules such as membrane proteins, thus contributing to new drug development opportunities in the pharmaceutical industry. Biotechnology, Antibody, Monoclonal antibody, VHH, membrane protein, Canine, … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 1 | 2 |